褪黑素抗衰老机制及其与缺血性卒中的关系

doi:10.3969/j.issn.1673-5765.2022.07.020

摘要/Abstract

摘要： 褪黑素具有显著抗衰老作用,其主要机制包括自由基清除和线粒体保护，褪黑素水平的下降可能是人体衰老的表现。此外，研究证实褪黑素具有降脂、降压和减重作用，可预防和延缓动脉粥样硬化进展，改善脑缺血再灌注损伤，在缺血性卒中领域具有良好的应用前景。本文对褪黑素抗衰老、预防卒中相关危险因素和改善卒中预后等方面的作用机制和应用前景进行总结。

文章导读： MT在预防卒中危险因素、延缓动脉粥样硬化进展以及改善缺血再灌注损伤方面均具有良好的应用前景，值得进一步探索。

关键词: 褪黑素; 抗衰老; 缺血性卒中

Abstract:

Melatonin has significant anti-aging effect, and the main action mechanisms includes free radical scavenging and mitochondrial protection. The decline of melatonin level may be the manifestation of human aging. In addition, it has been confirmed that melatonin has the effect of lipid-lowering, antihypertension and weight-loss, which can prevent and delay the progression of atherosclerosis, and reduce ischemia-reperfusion injury, so melatonin has a good application prospect in the field of ischemic stroke. This article summarized the mechanism and application prospect of melatonin in anti-aging, preventing stroke related risk factors and improving stroke prognosis.

Key words: Melatonin; Anti-aging; Ischemic stroke

张佳丽, 陈楚歆, 张心怡, 张宁, 王春雪. 褪黑素抗衰老机制及其与缺血性卒中的关系[J]. 中国卒中杂志, 2022, 17(07): 791-796.

ZHANG Jiali, CHEN Chuxin, ZHANG Xinyi, ZHANG Ning, WANG Chunxue. The Anti-aging Mechanism of Melatonin and Its Relationship with Ischemic Stroke[J]. Chinese Journal of Stroke, 2022, 17(07): 791-796.

参考文献

[1] MERCADO-SáENZ S，RUIZ-GóMEZ M J，MORALES-MORENO F，et al. Cellular aging：theories and technological influence[J]. Braz Arch Biol Technol，2010，53（6）：1319-1332.

[2] LOGAN R W，MCCLUNG C A. Rhythms of life：circadian disruption and brain disorders across the lifespan[J]. Nat Rev Neurosci，2019，20（1）：49-65.

[3] BAKER J，KIMPINSKI K. Role of melatonin in blood pressure regulation：an adjunct anti-hypertensive agent[J]. Clin Exp Pharmacol Physiol，2018，45（8）：755-766.

[4] IMENSHAHIDI M，KARIMI G，HOSSEINZADEH H. Effects of melatonin on cardiovascular risk factors and metabolic syndrome：a comprehensive review[J]. Naunyn Schmiedebergs Arch Pharmacol，2020，393（4）：521-536.

[5] NóBREGA-PEREIRA S，FERNANDEZ-MARCOS P J，BRIOCHE T，et al. G6PD protects from oxidative damage and improves healthspan in mice[J/OL]. Nat Commun，2016，7：10894[2021-12-20]. https://doi.org/10.1038/ncomms10894.

[6] REITER R J，TAN D X，ROSALES-CORRAL S，et al. Mitochondria：central organelles for melatonin's antioxidant and anti-aging actions[J/OL]. Molecules，2018，23（2）：509[2021-12-20]. https://doi.org/10. 3390/molecules23020509.

[7] BRATIC A，LARSSON N G. The role of mitochondria in aging[J]. J Clin Invest，2013，123（3）：951-957.

[8] ALEXEYEV M F. Is there more to aging than mitochondrial DNA and reactive oxygen species?[J]. FEBS J，2009，276（20）：5768-5787.

[9] HUO X K，WANG C，YU Z L，et al. Human transporters，PEPT 1/2，facilitate melatonin transportation into mitochondria of cancer cells：an implication of the therapeutic potential[J/OL]. J Pineal Res，2017，62（4）：e12390[2021-12-20]. https://doi.org/10.1111/jpi.12390.

[10] SUOFU Y，LI W，JEAN-ALPHONSE F G，et al. Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release[J/OL]. Proc Natl Acad Sci USA，2017，114（38）：e7997-e8006[2021-12-20]. https://doi.org/10. 1073/pnas. 1705768114.

[11] LUCKE-WOLD B P，TURNER R C，LUCKE-WOLD A N，et al. Age and the metabolic syndrome as risk factors for ischemic stroke：improving preclinical models of ischemic stroke[J]. Yale J Biol Med，2012，85（4）：523-539.

[12] STRAZZULLO P，D'ELIA L，CAIRELLA G，et al. Excess body weight and incidence of stroke：meta-analysis of prospective studies with 2 million participants[J/OL]. Stroke，2010，41（5）：e418-e426[2021-12-20]. https://doi.org/10.1161/strokeaha.109.576967.

[13] HUSSEIN M R，AHMED O G，HASSAN A F，et al. Intake of melatonin is associated with amelioration of physiological changes，both metabolic and morphological pathologies associated with obesity：an animal model[J]. Int J Exp Pathol，2007，88（1）：19-29.

[14] YANG W C，TANG K Q，WANG Y N，et al. Melatonin promotes triacylglycerol accumulation via MT2 receptor during differentiation in bovine intramuscular preadipocytes[J/OL]. Sci Rep，2017，7（1）：15080[2021-12-20]. https://doi.org/10.1038/s41598-017-12780-y.

[15] LIU K Q，YU W S，WEI W，et al. Melatonin reduces intramuscular fat deposition by promoting lipolysis and increasing mitochondrial function[J]. J Lipid Res，2019，60（4）：767-782.

[16] STACCHIOTTI A，FAVERO G，GIUGNO L，et al. Melatonin efficacy in obese leptin-deficient mice heart[J/OL]. Nutrients，2017，9（12）：1323[2021-12-20]. https://doi.org/10.3390/nu9121323.

[17] GAO T，WANG Z X，DONG Y L，et al. Role of melatonin in sleep deprivation-induced intestinal barrier dysfunction in mice[J/OL]. J Pineal Res，2019，67（1）：e12574[2021-12-20]. https://doi.org/10.1111/jpi.12574.

[18] SHARMA R，SAHOTA P，THAKKAR M M. Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus[J/OL]. J Pineal Res，2018，65（2）：e12498[2021-12-20]. https://doi.org/10.1111/jpi.12498.

[19] DELPINO F M，FIGUEIREDO L M. Melatonin supplementation and anthropometric indicators of obesity：a systematic review and meta-analysis[J/OL]. Nutrition，2021，91/92：111399[2021-12-20]. https://doi.org/10.1016/j.nut.2021.111399.

[20] GROSSMAN E，LAUDON M，ZISAPEL N. Effect of melatonin on nocturnal blood pressure：meta-analysis of randomized controlled trials[J/OL]. Vasc Health Risk Manag，2011，7：577-584[2021-12-20]. https://doi.org/10.2147/vhrm.s24603.

[21] OBAYASHI K，SAEKI K，TONE N，et al. Relationship between melatonin secretion and nighttime blood pressure in elderly individuals with and without antihypertensive treatment：a cross-sectional study of the HEIJO-KYO cohort[J]. Hypertens Res，2014，37（10）：908-913.

[22] PANDI-PERUMAL S R，BAHAMMAM A S，OJIKE N I，et al. Melatonin and human cardiovascular disease[J]. J Cardiovasc Pharmacol Ther，2017，22（2）：122-132.

[23] PANDI-PERUMAL S R，TRAKHT I，SRINIVASAN V，et al. Physiological effects of melatonin：role of melatonin receptors and signal transduction pathways[J]. Prog Neurobiol，2008，85（3）：335-353.

[24] REITER R J，TAN D-X，KORKMAZ A. The circadian melatonin rhythm and its modulation：possible impact on hypertension[J/OL]. J Hypertens Suppl，2009，27（6）：S17-S20[2021-12-20]. https://doi.org/10.1097/01.hjh.0000358832.41181.bf.

[25] AHSANOVA E，POPOV V，BULANOVA N，et al. Hypotensive action of melatonin in patients with arterial hypertension[J/OL]. Eur Cardiol，2020，15：e43[2021-12-20]. https://doi.org/10.15420/ecr.2020.15.1.po20.

[26] SCHEER F A，VAN MONTFRANS G A，VAN SOMEREN E J，et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension[J]. Hypertension，2004，43（2）：192-197.

[27] CAGNACCI A，CANNOLETTA M，RENZI A，et al. Prolonged melatonin administration decreases nocturnal blood pressure in women[J]. Am J Hypertens，2005，18（12）：1614-1618.

[28] SIMKO F，REITER R J，PAULIS L. Melatonin as a rational alternative in the conservative treatment of resistant hypertension[J]. Hypertens Res，2019，42（11）：1828-1831.

[29] MOHAMMADI-SARTANG M，GHORBANI M，MAZLOOM Z. Effects of melatonin supplementation on blood lipid concentrations：a systematic review and meta-analysis of randomized controlled trials[J]. Clin Nutr，2018，37（6）：1943-1954.

[30] AGIL A，NAVARRO-ALARCóN M，RUIZ R，et al. Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats[J]. J Pineal Res，2011，50（2）：207-212.

[31] CHAN T Y，TANG P L. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat[J]. Endocr Res，1995，21（3）：681-696.

[32] DAUCHY R T，BLASK D E，SAUER L A，et al. Physiologic melatonin concentration，omega-3 fatty acids，and conjugated linoleic acid inhibit fatty acid transport in rodent hind limb skeletal muscle in vivo[J]. Comp Med，2003，53（2）：186-190.

[33] DING S，LIN N，SHENG X，et al. Melatonin stabilizes rupture-prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor RORα-dependent manner[J/OL]. J Pineal Res，2019，67（2）：e12581[2021-12-20]. https://doi.org/10.1111/jpi.12581.

[34] MA S，CHEN J，FENG J，et al. Melatonin ameliorates the progression of atherosclerosis via mitophagy activation and NLRP3 inflammasome inhibition[J/OL]. Oxid Med Cell Longev，2018：9286458[2021-12-20]. https://doi.org/10.1155/2018/9286458.

[35] DOMINGUEZ-RODRIGUEZ A，ABREU-GONZALEZ P，GARCIA-GONZALEZ M，et al. Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction[J]. Atherosclerosis，2005，180（1）：101-105.

[36] KULESH A A，DROBAKHA V E，SHESTAKOV V V. The role of melatonin in the development of post-stroke cognitive impairment in elderly patients in comparison with middle-aged patients[J]. Adv Gerontol，2016，29（4）：651-657.

[37] LORENTE L，MARTíN M M，ABREU-GONZáLEZ P，et al. Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction[J]. J Int Med Res，2018，46（8）：3268-3277.

[38] LIU L，CAO Q，GAO W W，et al. Melatonin protects against focal cerebral ischemia-reperfusion injury in diabetic mice by ameliorating mitochondrial impairments：involvement of the Akt-SIRT3-SOD2 signaling pathway[J]. Aging，2021，13（12）：16105-16123.

[39] ZHAO Z W，LU C R，LI T J，et al. The protective effect of melatonin on brain ischemia and reperfusion in rats and humans：in vivo assessment and a randomized controlled trial [J/OL]. J Pineal Res，2018，65（4）：e12521[2021-12-20]. https://doi.org/10.1111/jpi.12521.

[40] YANG Y，JIANG S，DONG Y S，et al. Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice[J]. J Pineal Res，2015，58（1）：61-70.

[41] ZHANG R，NI L，DI X，et al. Potential role of melatonin as an adjuvant for atherosclerotic carotid arterial stenosis[J/OL]. Molecules，2021，26（4）：811[2021-12-20]. https://doi.org/10.3390/molecules26040811.